Rutgers Cancer Institute of New Jersey has partnered with top cancer centers across the nation to become a member of the Oncology Research Information Exchange Network (ORIEN). ORIEN is a collaboration among several premier cancer centers in North America focused on cancer care through precision medicine. Through ORIEN, Rutgers Cancer Institute is a participant in the Total Cancer Care® clinical trial.
In this trial, you can donate your tissue and clinical data for research to help physicians and scientists better understand cancer at the molecular level. Importantly, you are followed for life; if new drugs are identified that would match with your tumor's DNA (gene) changes, you will be notified.
For more information about the program, please contact:
Frances Di Clemente
Program Manager/ORIEN Program Manager
Rutgers Cancer Institute of New Jersey
Learn more about Rutgers Cancer Institute's participation in ORIEN and the Total Cancer Care® clinical trial